-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats
Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 1, Iss 7
Acknowledgements: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation
-
Ulipristal acetate (ellaOne) for emergency contraception: review of the clinical evidence
Kristina Gemzell-Danielsson,Sharon T Cameron
Review Article: Clinical Investigation